120 related articles for article (PubMed ID: 33358528)
1. [Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns].
Gochi Valdovinos A; Arriaga-Redondo M; Dejuan Bitriá E; Pérez Rodríguez I; Márquez Isidro E; Blanco Bravo D
An Pediatr (Engl Ed); 2020 Dec; ():. PubMed ID: 33358528
[TBL] [Abstract][Full Text] [Related]
2. Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns.
Gochi Valdovinos A; Arriaga-Redondo M; Dejuan Bitriá E; Pérez Rodríguez I; Márquez Isidro E; Blanco Bravo D
An Pediatr (Engl Ed); 2022 Feb; 96(2):138-144. PubMed ID: 35131219
[TBL] [Abstract][Full Text] [Related]
3. Antenatal magnesium sulphate and delayed passage of meconium: A multicentre study.
Toledano Revenga J; Peña-Moreno A; Arriaga-Redondo M; Márquez Isidro EM; Gochi Valdovinos A; Blanco Bravo D; Sánchez Luna M
An Pediatr (Engl Ed); 2022 Dec; 97(6):383-389. PubMed ID: 36202742
[TBL] [Abstract][Full Text] [Related]
4. [Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels].
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
An Pediatr (Barc); 2017 Mar; 86(3):135-141. PubMed ID: 27282203
[TBL] [Abstract][Full Text] [Related]
5. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
6. Effect of perinatal factors on time of first stool passage in preterm newborns: An open, prospective study.
Gulcan H; Gungor S; Tiker F; Kilicdag H
Curr Ther Res Clin Exp; 2006 May; 67(3):214-25. PubMed ID: 24678097
[TBL] [Abstract][Full Text] [Related]
7. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
8. Prevention of meconium obstruction in very low birth weight preterm infants.
Solaz-García AJ; Segovia-Navarro L; Rodríguez de Dios-Benlloch JL; Benavent-Taengua L; Castilla-Rodríguez DY; Company-Morenza MA
Enferm Intensiva (Engl Ed); 2019; 30(2):72-77. PubMed ID: 30245147
[TBL] [Abstract][Full Text] [Related]
9. Increased Risk of Meconium-Related Ileus in Extremely Premature Infants Exposed to Antenatal Magnesium Sulfate.
Sung SI; Ahn SY; Choi SJ; Oh SY; Roh CR; Yang M; Chang YS; Park WS
Neonatology; 2022; 119(1):68-76. PubMed ID: 35016173
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Antenatal Magnesium Sulfate for Neuroprotection in Extreme Prematurity: A Comparative Observational Study.
Bansal V; Desai A
J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):36-47. PubMed ID: 34393393
[TBL] [Abstract][Full Text] [Related]
11. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
12. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
Cuff RD; Sullivan SA; Chang EY
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
[No Abstract] [Full Text] [Related]
13. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
Havranek T; Ashmeade TL; Afanador M; Carver JD
Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
[TBL] [Abstract][Full Text] [Related]
14. Effects of magnesium sulfate in a newborn piglet meconium aspiration model.
Barrington KJ; Ryan CA; Finer NN
J Perinatol; 2000 Sep; 20(6):373-8. PubMed ID: 11002877
[TBL] [Abstract][Full Text] [Related]
15. Meconium stained amniotic fluid in preterm delivery is an independent risk factor for perinatal complications.
Mazor M; Hershkovitz R; Bashiri A; Maymon E; Schreiber R; Dukler D; Katz M; Shoham-Vardi I
Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 81(1):9-13. PubMed ID: 9846706
[TBL] [Abstract][Full Text] [Related]
16. Antenatal magnesium sulfate and the need for mechanical ventilation in the first three days of life.
Okito O; Aromolaran A; Massa-Buck B; Abdelatif D; Aly H; Mohamed MA
Pediatr Neonatol; 2023 Nov; 64(6):644-650. PubMed ID: 37280122
[TBL] [Abstract][Full Text] [Related]
17. Correlation between magnesium sulphate exposure in utero and serum calcium and alkaline phosphatase levels in preterm infants.
Kuraaki A; Shoko MU; Kazuhiro A
Magnes Res; 2022 Oct; 35(4):118-124. PubMed ID: 37052150
[TBL] [Abstract][Full Text] [Related]
18. Magnesium sulfate exposure and neonatal intensive care unit admission at term.
Girsen AI; Greenberg MB; El-Sayed YY; Lee H; Carvalho B; Lyell DJ
J Perinatol; 2015 Mar; 35(3):181-5. PubMed ID: 25321647
[TBL] [Abstract][Full Text] [Related]
19. Neonatal magnesium levels are safe after maternal MgSO
Dehaene I; Van Steenstraeten T; De Coen K; De Buyser S; Decruyenaere J; Smets K; Roelens K
Eur J Pediatr; 2022 Aug; 181(8):2971-2980. PubMed ID: 35595861
[TBL] [Abstract][Full Text] [Related]
20. Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU.
Ayed M; Ahmed J; More K; Ayed A; Husain H; AlQurashi A; Alrajaan N
Biomed Hub; 2022; 7(2):80-87. PubMed ID: 35950015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
